Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up
Abstract Various proteins play a decisive role in the pathology of different neurodegenerative diseases. Nonetheless, most of these proteins can only be detected during a neuropathological assessment, although some non-specific biomarkers are routinely tested for in the cerebrospinal fluid (CSF) as...
Guardado en:
Autores principales: | Magdalena Bruzova, Robert Rusina, Zuzana Stejskalova, Radoslav Matej |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de857d9a05f547e2872766e12499d608 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
por: Franc Llorens, et al.
Publicado: (2020) -
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
por: Niklas Mattsson-Carlgren, et al.
Publicado: (2020) -
The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
por: Agnieszka Kulczyńska-Przybik, et al.
Publicado: (2021) -
Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders
por: C. Delaby, et al.
Publicado: (2020) -
Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.
por: Walter Maetzler, et al.
Publicado: (2012)